Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

AC-0027875, a gamma-secretase modulator for the treatment of AD

April 29, 2022

University of California discloses new PRMT8 inhibitors

April 29, 2022

Study finds targets of T-cell response in multiple sclerosis

April 28, 2022

Herantis reports blood-brain barrier penetration data with HER-096 in dogs

April 28, 2022

WVE-004 shows promise for treating C9orf72-associated neurologic disorders

April 27, 2022

Virpax reports preclinical PK results for VRP-324 for management of seizures

April 27, 2022

RaQualia Pharma patents CRF2 receptor antagonists

April 27, 2022

n-Lorem receives funding to support ASO discovery for nano-rare neurodevelopmental diseases

April 22, 2022

Post viral infection, resting T-cell subtypes cooperate to drive neuroinflammation

April 22, 2022

Astrocyte-produced enzyme affects neuronal activity, stroke outcomes

April 21, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...